Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-17

FDA Approved: MESALAMINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for MESALAMINE from Actavis Pharma, Inc., resulting in approval of a supplemental to the approved generic product under …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)